Medical and Pharmaceutical International lung cancer screening market poised for steady growth: 2025 report It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says Rowan DunneMay 9, 2025
Medical and Pharmaceutical More X-ray referrals = more lung cancer survivors, study finds The disease can often be eliminated through surgery or targeted radiation in its early stages Rowan DunneMarch 31, 2025